Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Obesity is epidemic in Australia, and current preventative strategies have had limited
success in alleviating this health crisis. While numerous options are available for treatment
of obesity, most do not result in sustained weight reduction. Obesity results from an
imbalance between energy intake and expenditure, therefore new methods that correct this
imbalance are essential for effective long-term treatment. Rodent studies show that brown
adipose tissue (BAT) can burn more energy than any other tissue in the body, therefore
targeting BAT to increase its activity (energy burning rate) and quantity in humans is
potentially a powerful tool for the treatment of obesity and related diseases. BAT has only
recently been irrefutably identified in adult humans therefore little is known about how it
functions in humans.
Phase:
N/A
Details
Lead Sponsor:
Bayside Health
Collaborators:
Baker Heart and Diabetes Institute Baker IDI Heart and Diabetes Institute The Alfred